Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100 and RL100.
about
Sustained release spherical agglomerates of polymethacrylates containing mefenamic acid: in vitro release, micromeritic properties and histological studies.Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir.Bisoprolol and bisoprolol-valsartan compatibility studied by differential scanning calorimetry, nuclear magnetic resonance and X-ray powder diffractometry.Ocular application of chitosan.Eudragit: a technology evaluation.Design and optimization of diclofenac sodium controlled release solid dispersions by response surface methodologyPreparation of solid dispersions of nonsteroidal anti-inflammatory drugs with acrylic polymers and studies on mechanisms of drug-polymer interactions.Preparation and In Vitro Evaluation of Ethylcellulose and Polymethacrylate Resins Loaded Microparticles Containing Hydrophilic Drug.A novel preparation method for 5-aminosalicylic acid loaded Eudragit S100 nanoparticles.Hot melt extrusion as an approach to improve solubility, permeability and oral absorption of a psychoactive natural product, piperineChitosan nanoparticles for ocular delivery of cyclosporine A.Characterization of the mechanism of interaction in ibuprofen-Eudragit RL100 coevaporates.Tableting of Eudragit RS and propranolol hydrochloride solid dispersion: effect of particle size, compaction force, and plasticizer addition on drug release.QbD approach of rapid disintegrating tablets incorporating indomethacin solid dispersion.Hyperbranched polymers as drug carriers: microencapsulation and release kinetics.Self nanoemulsifying granules (SNEGs) of meloxicam: preparation, characterization, molecular modeling and evaluation of in vivo anti-inflammatory activity.Nanoparticle-based fluoroionophore for analysis of potassium ion dynamics in 3D tissue models andSolid‐State NMR Studies of Pharmaceutical SystemsSolid Dispersion: An Alternative Technique for Bioavailability Enhancement of Poorly Soluble Drugs
P2860
Q33809779-8ADCA5FE-730F-46C4-9308-0BA30AC343FDQ33986048-1BD6FA97-8645-44F8-B7F1-FF394C6D4156Q34990288-8D33C779-7DF8-4068-94BC-96C86DCDFB81Q38005199-10D773AB-5D5F-4B03-A17A-7597F9D1F209Q38055849-2C92966F-D629-4ED0-9CC6-38C111B91944Q39962816-17C45A64-5D5B-4746-899F-4C75E15F81CBQ40568609-D7FC0E91-CAE3-423F-8B34-919D165D2AA0Q41496595-2CF9C392-87F6-48D0-BAED-2E4EF5BE86C6Q41806951-29337F1A-00E4-4C7B-AA46-6FB3AD9D3365Q42433654-9501A8E8-6B50-44D0-8BD8-37419E57A478Q44640830-12EDBACD-D1F0-4152-8101-41EF6BF534E0Q44860987-E3F50A05-3AA5-4816-B5E2-5E6D2C4F07BFQ45111973-EEE4986A-5934-4724-BC95-179F22AC8135Q46671481-C2FD81FB-A2A9-4496-87D7-C72CC824CF42Q52934045-1FE3C6AC-D801-4EEE-AEA1-806357C606FFQ53689672-77553A08-F83E-42E8-AD41-AB4FF3A00041Q57147842-A5838085-CFA8-4D05-B8A2-123A0DB17C38Q57348567-C6F31E1B-16EA-4632-8D4E-57AE26D6E79DQ57378058-FB57F4EF-5EAE-4BE7-AAD9-578480CE1BDF
P2860
Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100 and RL100.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Preparation, characterisation ...... and Eudragit RS100 and RL100.
@en
Preparation, characterisation ...... and Eudragit RS100 and RL100.
@nl
type
label
Preparation, characterisation ...... and Eudragit RS100 and RL100.
@en
Preparation, characterisation ...... and Eudragit RS100 and RL100.
@nl
prefLabel
Preparation, characterisation ...... and Eudragit RS100 and RL100.
@en
Preparation, characterisation ...... and Eudragit RS100 and RL100.
@nl
P2093
P50
P1476
Preparation, characterisation ...... l and Eudragit RS100 and RL100
@en
P2093
P356
10.1016/S0378-5173(01)00597-X
P407
P577
2001-05-01T00:00:00Z